Shedding light on reimbursement policies of companion diagnostics in European countries (Published Online)
Publication typeVlerick strategic journal article
JournalValue in Health
MetadataShow full item record
AbstractEnsuring access to precision medicine has been an issue because in some European countries, desynchronized reimbursement decision-making occurs between the medicine and the companion diagnostic (CDx). This has resulted in cases in which precision medicine is reimbursed but not the CDx. In overcoming this issue, an alignment of the decision-making process for reimbursement between the 2 entities should be considered. As pharmaceutical reimbursement procedures are meticulously covered in the literature, we set out to systematically map in vitro diagnostic (IVD) reimbursement procedures and identify policies for aligning these procedures with the pharmaceutical reimbursement procedures.
Knowledge Domain/IndustrySpecial Industries : Healthcare Management